3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer

Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer

NCT01512810 ·Status: COMPLETED ·Phase: PHASE2

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

NCT04727242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding

NCT03330015 ·Status: COMPLETED

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

NCT07267780 ·Status: NOT_YET_RECRUITING

Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival

NCT05667259 ·Status: COMPLETED

Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma

NCT01560026 ·Status: UNKNOWN

Lymph Node Counts in Endometrial Cancer Staging

NCT02335775 ·Status: COMPLETED

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

NCT06524583 ·Status: RECRUITING ·Phase: PHASE2

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

NCT04504006 ·Status: RECRUITING

Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision

NCT06279299 ·Status: RECRUITING ·Phase: NA

Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer

NCT01679522 ·Status: COMPLETED ·Phase: NA

Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)

NCT03580421 ·Status: COMPLETED ·Phase: NA

Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

NCT05181306 ·Status: COMPLETED

Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer

NCT01946672 ·Status: COMPLETED ·Phase: PHASE4

Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC

NCT03708783 ·Status: UNKNOWN ·Phase: NA

Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer

NCT06728878 ·Status: RECRUITING

Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer

NCT03113318 ·Status: UNKNOWN ·Phase: NA

Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection

NCT02711033 ·Status: UNKNOWN ·Phase: PHASE2

Lymphedema in Endometrial Cancer

NCT01914276 ·Status: COMPLETED

Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study

NCT01919242 ·Status: UNKNOWN

The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer

NCT02792881 ·Status: UNKNOWN ·Phase: NA

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

NCT06014580 ·Status: ACTIVE_NOT_RECRUITING

Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy

NCT01518023 ·Status: COMPLETED

Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer

NCT01567917 ·Status: UNKNOWN

Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study

NCT06150222 ·Status: NOT_YET_RECRUITING